ClinicalTrials.gov record
Withdrawn Phase 3 Interventional

Double-blind Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy

ClinicalTrials.gov ID: NCT02527213

Public ClinicalTrials.gov record NCT02527213. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 5:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic Arteriolopathy Followed by a Single Armed Extension Phase to Prospectively Observe Lesion Progression

Study identification

NCT ID
NCT02527213
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 3
Lead sponsor
American Regent, Inc.
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • Placebo Drug
  • Sodium thiosulfate Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 29, 2015
Primary completion
Aug 28, 2016
Completion
Aug 28, 2016
Last update posted
May 6, 2025

2015 – 2016

United States locations

U.S. sites
3
U.S. states
3
U.S. cities
3
Facility City State ZIP Site status
Nephrology Consultants Huntsville Alabama 35805
Nephrology Association of Northern Indiana Fort Wayne Indiana 46804
A.A. Northeast Clinical Research Center Bethlehem Pennsylvania 18017

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02527213, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 6, 2025 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02527213 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →